Edition:
United Kingdom

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

2.30USD
16 Nov 2018
Change (% chg)

$0.24 (+11.65%)
Prev Close
$2.06
Open
$2.06
Day's High
$2.34
Day's Low
$2.06
Volume
47,848
Avg. Vol
32,038
52-wk High
$4.55
52-wk Low
$1.68

Chart for

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $33.86
Shares Outstanding(Mil.): 24.17
Dividend: --
Yield (%): --

Financials

  APTO.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -0.80 -- --
ROI: -123.77 -0.64 15.05
ROE: -123.77 0.08 16.62

Earnings vs. Estimates